DXCMDEXCOM INC

Nasdaq dexcom.com


$ 124.38 $ -13.67 (-9.91 %)    

Friday, 26-Apr-2024 15:59:55 EDT
QQQ $ 431.01 $ 6.55 (1.54 %)
DIA $ 382.27 $ 1.39 (0.36 %)
SPY $ 508.26 $ 4.77 (0.95 %)
TLT $ 88.26 $ 0.46 (0.52 %)
GLD $ 216.60 $ 0.70 (0.32 %)
$ 124.34
$ 132.66
$ 0.00 x 0
$ 0.00 x 0
$ 124.28 - $ 137.66
$ 74.75 - $ 142.00
8,578,184
na
51.81B
$ 1.17
$ 81.05
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 04-25-2024 03-31-2024 10-Q
2 02-08-2024 12-31-2023 10-K
3 10-26-2023 09-30-2023 10-Q
4 07-27-2023 06-30-2023 10-Q
5 04-27-2023 03-31-2023 10-Q
6 02-09-2023 12-31-2022 10-K
7 10-27-2022 09-30-2022 10-Q
8 07-28-2022 06-30-2022 10-Q
9 04-28-2022 03-31-2022 10-Q
10 02-14-2022 12-31-2021 10-K
11 10-28-2021 09-30-2021 10-Q
12 07-29-2021 06-30-2021 10-Q
13 04-29-2021 03-31-2021 10-Q
14 02-11-2021 12-31-2020 10-K
15 10-27-2020 09-30-2020 10-Q
16 07-28-2020 06-30-2020 10-Q
17 04-28-2020 03-31-2020 10-Q
18 02-13-2020 12-31-2019 10-K
19 11-06-2019 09-30-2019 10-Q
20 07-31-2019 06-30-2019 10-Q
21 05-01-2019 03-31-2019 10-Q
22 02-21-2019 12-31-2018 10-K
23 11-06-2018 09-30-2018 10-Q
24 08-01-2018 06-30-2018 10-Q
25 05-02-2018 03-31-2018 10-Q
26 02-27-2018 12-31-2017 10-K
27 11-01-2017 09-30-2017 10-Q
28 08-01-2017 06-30-2017 10-Q
29 05-02-2017 03-31-2017 10-Q
30 02-28-2017 12-31-2016 10-K
31 11-01-2016 09-30-2016 10-Q
32 08-02-2016 06-30-2016 10-Q
33 04-27-2016 03-31-2016 10-Q
34 02-23-2016 12-31-2015 10-K
35 11-04-2015 09-30-2015 10-Q
36 08-05-2015 06-30-2015 10-Q
37 04-29-2015 03-31-2015 10-Q
38 02-25-2015 12-31-2014 10-K
39 11-06-2014 09-30-2014 10-Q
40 08-06-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 raymond-james-maintains-strong-buy-on-dexcom-raises-price-target-to-160

Raymond James analyst Jayson Bedford maintains DexCom (NASDAQ:DXCM) with a Strong Buy and raises the price target from $151 ...

 canaccord-genuity-maintains-buy-on-dexcom-raises-price-target-to-145

Canaccord Genuity analyst William Plovanic maintains DexCom (NASDAQ:DXCM) with a Buy and raises the price target from $144 t...

 dexcom-q1-2024-adj-eps-032-beats-027-estimate-sales-921000m-beat-909238m-estimate

DexCom (NASDAQ:DXCM) reported quarterly earnings of $0.32 per share which beat the analyst consensus estimate of $0.27 by 18.52...

 ubs-maintains-buy-on-dexcom-raises-price-target-to-163

UBS analyst Danielle Antalffy maintains DexCom (NASDAQ:DXCM) with a Buy and raises the price target from $153 to $163.

 citigroup-maintains-buy-on-dexcom-raises-price-target-to-161

Citigroup analyst Joanne Wuensch maintains DexCom (NASDAQ:DXCM) with a Buy and raises the price target from $148 to $161.

 micron-dropbox-and-2-other-stocks-insiders-are-selling

The Nasdaq 100 closed lower by around 0.1% on Thursday. Investors, meanwhile, focused on some notable insider trades.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION